# 04_QA_REPORT.md

# Quality Assurance Report

---

# Identity

| Field | Value |
|-------|-------|
| QA Report ID | QA-PP-0116 |
| Population Package | PP-0116 |
| Version | 1.0.0 |
| Review Status | PASS |

---

# Layer 1 — Content QA

| Criterion | Result |
|-----------|--------|
| Single educational question | PASS |
| Scope respected | PASS |
| Complete coverage | PASS |
| Internal consistency | PASS |
| Logical organization | PASS |
| Knowledge blocks complete | PASS |
| No overlap with adjacent Population Packages | PASS |

---

# Layer 2 — Clinical QA

| Criterion | Result |
|-----------|--------|
| Scientifically accurate | PASS |
| Consistent with ACMG | PASS |
| Consistent with AMP | PASS |
| Consistent with ClinGen | PASS |
| Consistent with CAP | PASS |
| Consistent with NCI | PASS |
| Consistent with NCCN | PASS |
| Consistent with ASCO | PASS |
| Consistent with ACS | PASS |
| Consistent with ESMO | PASS |
| Appropriate explanation of ACMG Evidence Codes | PASS |
| Appropriate explanation of evidence-based variant interpretation | PASS |
| Appropriate distinction between evidence codes and final variant classification | PASS |
| No unsupported clinical claim | PASS |
| No unsafe medical advice | PASS |

---

# Layer 3 — Educational QA

| Criterion | Result |
|-----------|--------|
| Plain language | PASS |
| Appropriate for patients | PASS |
| Learning objectives satisfied | PASS |
| Common misconceptions addressed | PASS |
| Appropriate explanation of standardized evidence documentation | PASS |
| Appropriate clarification that patients are not expected to interpret individual evidence codes | PASS |
| Encourages discussion with healthcare professionals | PASS |

---

# Layer 4 — Governance QA

| Criterion | Result |
|-----------|--------|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Evidence Package completed | PASS |
| Evidence traceability complete | PASS |
| Scope maintained | PASS |
| Knowledge Graph complete | PASS |
| Versioning complete | PASS |
| Repository compliant | PASS |

---

# Clinical Safety Review

| Item | Result |
|------|--------|
| No unsafe medical advice | PASS |
| No unsupported interpretation guidance | PASS |
| Appropriate clarification that evidence codes are professional tools | PASS |
| Appropriate clarification that evidence codes are not genetic test results | PASS |
| Appropriate explanation that final classifications are based on multiple evidence sources | PASS |
| No disease-specific treatment recommendations | PASS |

---

# Educational Boundary Review

The Population Package successfully remains within the predefined educational boundary.

Included:

- definition of ACMG Evidence Codes;
- purpose of standardized evidence documentation;
- role in variant interpretation;
- relationship with final variant classification;
- patient implications.

Excluded:

- individual evidence codes;
- evidence strength hierarchy;
- Bayesian framework;
- computational prediction methods;
- functional evidence;
- population databases;
- ClinVar workflow;
- laboratory implementation;
- treatment recommendations.

The **Atomic Knowledge Principle** has been fully preserved.

---

# Final Quality Decision

## PASS

PP-0116 satisfies the locked **Gold Population Package Specification v1.0**.

Approved as the official Population Package for:

> **PP-0116 — ACMG Evidence Codes**

---

# Reviewer Notes

This Population Package establishes the repository's **evidence-governance foundation** for clinical genomics. While **PP-0115** explains the overall ACMG Variant Classification Framework, **PP-0116** introduces the standardized evidence language that powers that framework. It helps patients understand that genomic classifications are derived from **multiple structured sources of scientific evidence**, not subjective opinion, while deliberately avoiding the technical details of individual evidence codes. This package serves as the gateway to the next educational layer covering the individual ACMG evidence-code families, beginning with **PVS1 (Very Strong Pathogenic Evidence)**.